Teenage years crucial for depression intervention, study finds
Depression in young teens could be easier to treat than in adulthood due to the symptoms being more flexible and not yet ingrained, a study shows. Researchers found… read more.
Depression in young teens could be easier to treat than in adulthood due to the symptoms being more flexible and not yet ingrained, a study shows. Researchers found… read more.
GSK plc announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Blenrep is approved for the treatment of adults with… read more.
Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower… read more.
One hundred days into the new federal administration, a new poll reports that major segments of the U.S. public anticipate they will lose trust in public health recommendations… read more.
J&J announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended expanding the Marketing Authorisation for Tremfya (guselkumab) to… read more.
The total economic burden of Alzheimer’s disease and related dementias in the United States will reach $781 billion this year, according to new USC-led research. This is the first… read more.
Emergency Medicine & Intensive Care
In a new clinical study published in JAMA Pediatrics, researchers at the University of Chicago Medicine found that a low-intensity program that “prescribes” community resources to every parent or other primary… read more.
Roche announced that the Phase III MUSETTE trial comparing a high dose of Ocrevus (ocrelizumab) intravenous (IV) infusion to the currently approved Ocrevus IV 600 mg dose in… read more.
Even though microbial keratitis is a preventable cause of blindness, it’s a complex infection to treat, and many patients have lasting vision impairment. Previous studies have identified several… read more.
Caltech professor of medical engineering Wei Gao and his colleagues are envisioning a smart bandage of the future—a “lab on skin” that could not only help patients and… read more.
Teva Pharmaceutical Industries Ltd. , and Samsung Bioepis Co., Ltd. announced the availability of Epysqli (eculizumab-aagh) in the U.S. Epysqli is a biosimilar to Soliris (eculizumab) for the… read more.
The first clinical trial to test whether adults allergic to peanuts can be desensitised has shown great success with two thirds of the cohort consuming the equivalent of… read more.